1. Home
  2. ZLAB vs ASH Comparison

ZLAB vs ASH Comparison

Compare ZLAB & ASH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Zai Lab Limited

ZLAB

Zai Lab Limited

HOLD

Current Price

$25.52

Market Cap

2.6B

Sector

Health Care

ML Signal

HOLD

Logo Ashland Inc.

ASH

Ashland Inc.

HOLD

Current Price

$73.15

Market Cap

3.1B

ML Signal

HOLD

Company Overview

Basic Information
Metric
ZLAB
ASH
Founded
2013
1924
Country
China
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Specialty Chemicals
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
2.6B
3.1B
IPO Year
2017
2016

Fundamental Metrics

Financial Performance
Metric
ZLAB
ASH
Price
$25.52
$73.15
Analyst Decision
Strong Buy
Buy
Analyst Count
5
7
Target Price
$49.60
$65.57
AVG Volume (30 Days)
983.0K
799.2K
Earning Date
05-07-2026
04-28-2026
Dividend Yield
N/A
3.38%
EPS Growth
38.46
N/A
EPS
N/A
0.43
Revenue
$460,156,000.00
$1,824,000,000.00
Revenue This Year
$9.75
$2.58
Revenue Next Year
$26.03
$4.28
P/E Ratio
N/A
$172.49
Revenue Growth
15.33
N/A
52 Week Low
$15.96
$46.30
52 Week High
$35.45
$78.25

Technical Indicators

Market Signals
Indicator
ZLAB
ASH
Relative Strength Index (RSI) 73.93 56.46
Support Level $16.98 $58.70
Resistance Level $26.66 $74.99
Average True Range (ATR) 1.18 2.18
MACD 0.57 -0.21
Stochastic Oscillator 87.07 26.37

Price Performance

Historical Comparison
ZLAB
ASH

About ZLAB Zai Lab Limited

Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. Zai Lab has a diverse pipeline of potentially first-in-class product candidates developed through in-house R&D and global partnerships. The company has successfully commercialized several products in China, including Zejula, Optune, Qinlock, and Nuzyra, with plans for further expansion The pipeline of proprietary drug candidates of the company includes ZL-1222, ZL-1311, ZL-6201 and many others.

About ASH Ashland Inc.

Ashland Inc. is a specialty materials company serving markets including pharmaceuticals, personal care, food and beverages, coatings, construction, energy, and electronics. It operates through four segments: Life Sciences, Personal Care, Specialty Additives, and Intermediates. Life Sciences contributes the highest revenue, offering functional additives for pharmaceutical and nutrition applications. Personal Care provides ingredients for skin, hair, oral care, and household products, while Specialty Additives supplies performance-enhancing additives for coatings and. Intermediates produce BDO and related derivatives used in polymers, electronics, agriculture, and pharmaceutical applications. The company generates sales across North America, Europe, Asia Pacific, Latin America, and regions.

Share on Social Networks: